Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1997 1
1999 2
2000 3
2002 6
2003 7
2004 5
2005 9
2006 10
2007 15
2008 31
2009 28
2010 27
2011 30
2012 34
2013 37
2014 39
2015 40
2016 36
2017 38
2018 28
2019 29
2020 22
2021 27
2022 41
2023 41
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, Martens FMAC, Steg PG, Visseren FLJ. Burger PM, et al. Among authors: visseren flj. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 27:pvae030. doi: 10.1093/ehjcvp/pvae030. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38678009
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
Helmink MAG, Peters SAE, Westerink J, Harris K, Tillmann T, Woodward M, van Sloten TT, van der Meer MG, Teraa M, Dorresteijn JAN, Ruigrok YM, Visseren FLJ, Hageman SHJ; UCC-SMART study group. Helmink MAG, et al. Among authors: visseren flj. Eur J Prev Cardiol. 2024 Apr 8:zwae096. doi: 10.1093/eurjpc/zwae096. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 38584392
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
Helmink MAG, Hageman SHJ, Eliasson B, Sattar N, Visseren FLJ, Dorresteijn JAN, Harris K, Peters SAE, Woodward M, Szentkúti P, Højlund K, Henriksen JE, Sørensen HT, Serné EH, van Sloten TT, Thomsen RW, Westerink J. Helmink MAG, et al. Among authors: visseren flj. Diabetes Obes Metab. 2024 Jun;26(6):2229-2238. doi: 10.1111/dom.15531. Epub 2024 Mar 8. Diabetes Obes Metab. 2024. PMID: 38456579
Prevalence and determinants of self-reported low-fat-, low-salt-, and vegetarian diets in patients with cardiovascular disease between 1996 and 2019.
Hoes LLF, Geleijnse JM, Bonekamp NE, Dorresteijn JAN, van der Meer MG, van der Schouw YT, Visseren FLJ, Koopal C; UCC-SMART study group. Hoes LLF, et al. Among authors: visseren flj. Nutr Metab Cardiovasc Dis. 2024 Apr;34(4):935-943. doi: 10.1016/j.numecd.2024.01.015. Epub 2024 Jan 14. Nutr Metab Cardiovasc Dis. 2024. PMID: 38403481 Free article.
Impact of the 2021 European Society for Cardiology prevention guideline's stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease.
Holtrop J, Bhatt DL, Ray KK, Mach F, Smulders YM, Carballo D, Steg PG, Visseren FLJ, Dorresteijn JAN. Holtrop J, et al. Among authors: visseren flj. Eur J Prev Cardiol. 2024 Apr 18;31(6):754-762. doi: 10.1093/eurjpc/zwae038. Eur J Prev Cardiol. 2024. PMID: 38324720
510 results